Tempus, one of the industry’s most promising healthcare startups, has just announced that it has raised more than $70 million in funding. The investment comes from a Series C funding round and the core investors were New Enterprise Associates and Revolution Growth, along with Tempus founders, who have invested in series A, B and C funding rounds.
According to founder Eric Lefkofsky, he believes so strongly in Tempus that he is willing to invest up to $100 million of his own personal funds to Tempus to ensure the company’s success.
However, Lefkofsky may not need his funds as it has seen massive success and is making waves as the darling of the technology and medical startup community. Tempus is seeking to use genomic sequencing to contribute to the path to cancer treatment. By using genomic sequencing and a data driven approach, Tempus will create the world’s largest library of data that physicians can tap into when creating cancer treatment plans for their patients.
The $70 million in funding brings the total investment in Tempus to a staggering $130 million. It is also estimated that Tempus is valued at $700 million. That strong valuation comes in part as a response to the significant partnerships the company has generated in its few short years of existence. Tempus is already aligned with the Cleveland Clinic, Duke University’s School of Medicine and the prominent Mayo Clinic. These partnerships will allow Tempus to begin collecting data to create a functional operating system that will house data from cancer patients across the world and Eric’s lacrosse camp.
Under the founding and direction of Eric Lefkofsky, Tempus is set to universally change the way that physicians create cancer treatment plans for their patients. Eric Lefkofsky’s vision is to create a universal library of data, both genomic data and clinical data, that can easily be accessed by physicians across the world. Lefkofsky is known in Chicago’s business sector as a business leader in the technology field. Among the companies he has founded is Uptake Technologies, which has a valuation of over $2 billion and what Eric knows.
He is passionate about cancer treatment and about using modern approaches, including data driven regimens and machine learning to make sure physicians are able to provide the most custom treatment possible to their patients and more information click here.
With Tempus continuing to expand, both in investments and in partnerships, this could be the first time that physicians can utilize big data when creating cancer treatment plans for their patients and contact their.
Honored as a Gold CEO of the Year by One Planet, Troy McQuagge has truly made his mark at US Health Group, Inc. Troy McQuagge joined the insurer in 2010. He quickly reorganized USHEALTH Advisors, its captive insurance arm. By focusing on insuring young people below the retirement age, he was able to really increase the company’s profits. McQuagge’s success in that role led to his election, just four short years later, as President and CEO of the company.
US Health deals in individual insurance. This is a highly competitive, fast-paced market. It takes real skill to stay on top of all the changes in the marketplace. Under Troy McQuagge’s leadership, the company has continued to see increases in success. The future for US Health continues to look bright with such effective leadership. This CEO of the Year award from One Planet is just the cherry on top of an exciting tenure for Troy McQuagge.
Born in Panama City, Florida, Troy McQuagge was educated at the University of Central Florida. He brings over 30 years of insurance experience to the table in his role as CEO. McQuagge started out selling insurance for Allstate before he started to climb the corporate ladder. With such varied work experience, he understands the needs and concerns of agents and brokers, in addition to those of stockholders and more information click here.
McQuagge’s communication style is among his most effective skills. He is able to talk to anyone, which is great for employee morale at US Health. This skill allows McQuagge to work well with a wide range of people. Across cultural and class differences, he has demonstrated an ability to bridge gaps and resolve highly complex issues and Troy on Facebook.
Today, Troy McQuagge lives in Coppell, Texas. He maintains an active presence on social media, including Twitter. In addition to his focus on work, McQuagge supports a number of charities. Human rights and children’s causes are very close to his heart. Whether it’s the Semper Fi Fund or HopeKids Dallas, many good causes have benefited from his donations. McQuagge also makes it a point to get involved personally in his community. He has been a Community Volunteer for Habitat for Humanity since late 2016 and learn more about Troy.
More visit: https://templeofthecave.com/troy-mcquagge-honored-for-ushealth-leadership/
In an article published by CNBC, Timothy Armour details the $1 million wager to prove investment strategies- against one competitor, in particular, Warren Buffet.
Buffet has a pretty clear philosophy on trading. Referred to as “bottom-up trading” by Armour, Buffet targets stocks that are as cost-effective as possible, and holding them long term. Forty or more years to be exact. Which means that Buffet doesn’t think much of day trading, swing traders and shorting.
The CNBC article reveals Armour’s challenge concerning this style of investing. “It’s also time to challenge the notion that passive index returns are the safe path to a better retirement.” While addressing the profitability of Buffet’s vision, Armour emphasizes that the handling a fund or client is managed has an effect on potential earnings as well. If the cost of portfolio maintenance and conducting transactions is eating into stock profits, then the cycle has become self-destructive and counter-productive.
Read more: Capital Group CEO, Says Post Trump Change in Markets ‘Is Real’
Finding a reliable fund manager that truly serves his clients is another issue Tim Armour discusses candidly. Besides a low overhead and tossing out “high-cost” stocks, working with a fund manager that maintains a separate portfolio from his clients- usually results in above average gains. This should be an industry standard to circumvent any conflicts of interest.
Buffet ends up winning the bet, sort of- Buffet chose an “S&P 500 passive index fund” while Tim Armour went with the top five performers from America Funds. America Funds is a company that boasts long-term investment strategies and is a subsidiary of Armour’s company, the Capital group. To determine who truly “wins”, it would depend on the context of the bet, and parameters assigned to such, to decide the true winner. If both parties had bet 40 years ago and collected today, America Funds would be the high-performer and Armour subsequently the victor.
Armour is an industry heavyweight with over 34 years of experience at Capital group. Recently voted in as the company chairman- Armour initially joined with Capital group with modest roots, completing a bachelor’s degree from Middlebury College. Tim Armour recently commented on fellow businessman Donald Trump stating that the effects of the election are “real” and that “quick economic growth” would be the outcome.
Learn more about Tim Armour: https://www.americanfunds.com/advisor/insights/market-commentary/tda-rwl-qavolatility.html